Free Essay

Chronic Obstructive Pulmonary Disease

In: Other Topics

Submitted By mareee
Words 3574
Pages 15
Chronic Obstructive Pulmonary Disease |

We are doing a case study on medical, nursing, pharmacological management of COPD (Chronic Obstructive Pulmonary Disease). We took a COPD patient and assessed the patient for clinical manifestation, the medical, nursing, pharmacological care given to the patient. In our case study we will include the care Hawwa is receiving now and the care we can add to daily routine to help her recover faster.
Hawwa Ismail is admitted to Medical ward with diagnosis of COPD. She is 145cm tall, slim, with dark complexion. She is 79 years old. She said that she has difficulty in breathing, she cannot sleep in night time ,she do not feel like eating food and she was having cough.
Physical assessment revealed BP 138/47mmHg right arm in lying position, pulse 84 regular and strong, and breathing pattern was irregular labored, tachypnic at 40 breathes per minute,SpO2 99% in room air and temperature 360C (96.80F).Her facial color and lips are ruddy, but nails are clean ,pale and clubbed. She has a little barrel chest, uses accessory muscle to breathe. She has prolonged expiration. While auscultating lungs, diminished breath sound in most of the lower lobes and a small wheezing sound in right lower lobe was noted.


PATIENT NAME: Hawwa Ismail


NAME: Abdul HameedHussain
CONTACT NO: 7772099

AGE: 79yrs
SEX: female

RACE: Asian


OCCUPATION: House wife

EDUCATION LEVEL: Basic Education
EATING HABITS: she eats twice a day, mostly garudiya and rice

PRESENT HISTORY: 79 year old female (Hawwa Ismail) came to casualty with the complaints of productive cough, decreased appetite, fever and body ache since one week. On admission vitals were as following; BP: 114/77mmHg, Pulse: 100/min, SpO2: 99%, temp: 100oF, RR: 40/min and patient had wheezing right lower zone of chest, patient was conscious and oriented.
PAST HISTORY: known case of IgM multiple myeloma (II), NSTEMI (Non ST elevation myocardial infarction), upper lobe pneumonia with secondary bronchiectasis, oral candidiasis. Previously admitted in medical ward related multiple myeloma and NSTEMI, one year backand patient was diagnosed for COPD two years back.
FAMILY HISTORY:Nil significant informed.

DEFINITION:group of pulmonary disorder characterized by air flow limitation that is not fully reversible. (Smeltzer,Bare,Hinkle&Cheever,2010,p.602)
1. 2. Emphysema 3. Bronchitis

DEFINITION:a disease of the airway is defined as presence of cough and sputumproduction for at least 3 months in each 2 consecutive years.(Smeltzer,Bare,Hinkle&Cheever,2010,p.602)
INCIDENCE: The WHO estimates that in 2000, 2.74 million people died of COPD worldwide. Mortality of COPD among women has increased since 2nd world war in 2005, more women than men died of COPD. An additional 12 million Americans may have COPD but remain undiagnosed
Smoke or other environmental pollutant irritates the airways (Smeltzer,,2010,p.602) |

Resulting in hyper secretion of mucus and inflammation
Constant irritation causes the mucus-secreting glands and goblet cells to increase in number.
Ciliary function reduces and more mucus is produced.

Bronchial walls become thickened; the bronchial lumen narrows and mucus plug the airway

Airway obstruction
RISK FACTOR: * Exposure to tobacco smoke accounts for an estimated 80% to 90% COPD cases. * Passive smoking * Occupational exposure * (Smeltzer,Bare,Hinkle&Cheever,2008,p.688)
Ambient air pollution * Genetic abnormalities
She is exposed to dust while cleaning the house, before she used to cook with wood so she was exposed to smoke regularly. She is exposed to cigarette smoke because many people in her house smokes.
* Airway obstruction * Diffuse airway injury * Pulmonary infection and obstruction of the bronchus or complications of long-term pulmonary infections. * Genetic factors * Abnormal host defense * Idiopathic causes
She had a history of pneumonia a pulmonary infection leading to chronic obstructive pulmonary disease. SIGNS AND SYMPTOM * COPD is characterized by three primary symptoms: * Chronic cough * Sputum production * Dyspnea on exertion * Weight loss is common, because Dyspnea interferes with eating the work of breathing is energy-depleting * Use of accessory muscle * Patients with COPD are at risk for respiratory insufficiency and respiratory infections, which in turn increase the risk of acute and chronic respiratory failure. * Barrel chest * Shortness of breath * Wheezing * Prolonged expiration * Enlarged heart clubbing of nails. * (Smeltzer,Bare,Hinkle&Cheever,2008,p.689)
* Peripheral edema SIGNS AND SYMPTOM IN HAWWA: She has excessive mucus production, as a way of elimination coughing is present. She is having dyspnea, shortness of breath and wheezing. Prolonged coughing and dyspnea and use of accessory muscle, increase work load of chest leads to barrel chest and she feel tired. Her nails are clubbed. Presences of other diseases such as myocardial infarction make her immunosuppressed to other pulmonary infections. ASSESSMENT AND DIAGNOSTICS FINDINGS ASSESSMENT * Obtain history * Ask about exposure to risk factors * Family history * Pattern of symptoms developed * History of previous hospitalization * Appropriateness of current treatment * Impact of the disease on quality of life * Available social and family support for patient * Potential for reducing risk factors. DIAGNOSTIC TESTS * Pulmonary function studies: helps to confirm the diagnosis of COPD, determine disease severity, and monitor disease progression * Spirometry: to evaluate airway obstruction, by ratio of FEV, to forced vital capacity (FVC). * Arterial blood gas measurement: to assess baseline oxygenation and gas exchange. * X-ray or Computer tomography (CT) scan: to check presence or absence of bronchial dilation. In Hawwa, in addition to above diagnostic tests her sputum culture was sent to test for pulmonary infections. (Smeltzer,Bare,Hinkle&Cheever,2008,p.689)

Investigation done on 19th June 2012 Haematology Name of test | Result | Normal Range | Remarks | Haemoglobin | 7.1 g/dL | 11.5-17 | low | PCV | 22.1% | 35-48 | low | Total leukocyte count | 2.18x10^3/uL | 4-11 | low | Differential count | | | | Neutrophils | 56.0% | 40-72 | Normal | Lymphocytes | 32.1% | 20-40 | Normal | Monocytes | 10.1% | 2-10 | Normal | Eosinophils | 1.8% | 1-6 | Normal | Basophils | 0.0% | 0-1 | Normal | Platelet count | 56x10^3/uL | 150-400 | Very low | erythrocyte sedimentary rate (ESR) | 95 | 1-15 | High |

When we saw the reports of 19th June we came to know that patient’s haemoglobin was low and she was given two pints of blood. After transfusing two pints of blood her haemoglobin was increased. Increase ESR indicates inflammation and decrease leukocyte count show that she was having an infection for which she was treated with antibiotics. Decreased number of platelets indicates risk of bleeding.

Investigation done on 21st June 2012
Mantouxtest:To test for positivity or negativity of tuberculosis Test | 10 tuberculin unit PPD given intradermally | Date of administration | 21/6/2012 | Date reading | 23/6/2012 | Indurations | 00mm |
Investigation done on 23rdJune 2012

Name of test | Result | Normal Range | Remarks | ESR | 95mm/1Hr | 1-15 | HIGH | CRP | 41mg/l | 0-10 | HIGH |

CLINICAL CHEMISTRY. Name of test | Result | Normal Range | Remarks | Blood urea | 13.5mg/dl | 15-36 | low | Serum Sodium | 136.1mmol/l | 137-145 | Normal | Serum Potassium | 2.94mmol/l | 3.5-5.1 | low | Serum Creatinin | 0.9 mg/dl | 0.7-1.2 | Normal |
Investigation done on 23rd June 2012 Haematology Name of test | Result | Normal Range | Remarks | Differential count | | | | Neutrophils | 66.6% | 40-72 | Normal | Lymphocytes | 20.3% | 20-40 | Normal | Monocytes | 15% | 2-10 | High | Eosinophils | 2.0% | 1-6 | Normal | Basophils | 1% | 0-1 | Normal | Platelet count | 56x10^3/ul | 150-400 | Very low | ESR | 84 | 1-15 | High |

Investigation done on 24th june2012

CLINICAL CHEMISTRY. Serum Sodium | 131.9mmol/l | 137-145 | Normal | Serum Potassium | 3.46mmol/l | 3.5-5.1 | Normal |
Investigation done on 25thjune 2012 Haematology Name of test | Result | Normal Range | Remarks | Haemoglobin | 11.2 g/dl | 11.5-17 | Normal | Total leucocyte count | 3.39x10^3/ul | 4-11 | low | Differential count | | | | Neutrophils | 46.9% | 40-72 | Normal | Lymphocytes | 33.7% | 20-40 | Normal | Monocytes | 14.9% | 2-10 | High | Eosinophils | 3.4% | 1-6 | Normal | Basophils | 1.1% | 0-1 | Normal | Platelet count | 101x10^3/ul | 150-400 | low | ESR | 51 | 1-15 | High |

MEDICAL MANAGEMENT RISK REDUCTION Smoking cessation: Smokingparalyzesciliary action, increasing bronchial secretions. PHARMACOLOGICAL THERAPY 1. Bronchodilators: * To relive bronchospasm * To reduce airway obstruction * Improve alveolar ventilation 2. Corticosteroids: inhaled corticosteroids (oral or intravenous) may be used to relieve bronchospasm. 3. Vaccination against diseases such as influenza, pneumonia is given to prevent infection. 4. Oxygen therapy: to prevent acute dyspnea. (Smeltzer,Bare,Hinkle&Cheever,2008,p.691)

MEDICATIONS HAWWA RECEIVES: Generic Name | Cefotaxime | Brand names | Claforan | Caution | sensitivity to beta-lactam antibacterials (avoid if history of immediate hypersensitivity reaction),false positive urinary glucose (if tested for reducing substances) and false positive Coombs’ test | Indication | Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.Cefotaxim was given for patient because she was having infections. | Dosage | 1g, IV, TDS (3 times a day) | Contraindication | cephalosporin hypersensitivity | Side effects | diarrhoea (rarely antibiotic-associated colitis), nausea and vomiting, abdominal discomfort, headache; allergic reactions including rashes, pruritus, urticaria, serum sickness-like reactions with rashes, fever and arthralgia, and anaphylaxis; Stevens-Johnson syndrome, toxic epidermal necrolysis reported; disturbances in liver enzymes, transient hepatitis and cholestatic jaundice; other side effects reported include eosinophilia and blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia); reversible interstitial nephritis, hyperactivity, nervousness, sleep disturbances, hallucinations, confusion, hypertonia, and dizzinessno side effect seen in patient | Pharmacodynamics | Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against Pseudomonas aeruginosa. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it displays a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives. | Mechanism of action | The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III. | Nursing implication | Monitor for adverse reaction. | Name | Pantoprazole | Brand names | Astopan, Pantoloc, Pantoc, Pantozol, Protium, protonix | Caution | Proton pump inhibitors may mask the symptoms of gastric cancer; particular care is required in those presenting with ‘alarm features’, in such cases gastric malignancy should be ruled out before treatment. A proton pump inhibitor should be prescribed for appropriate indications at the lowest effective dose for the shortest period; the need for long-term treatment should be reviewed periodically. | Indication | Gastro-oesophageal Disease | Contraindication | Nil | Dosage | 40mg, IV, BD (2 times a day) | Side effects | Side effects of the proton pump inhibitors include gastro-intestinal disturbances (including nausea, vomiting, abdominal pain, flatulence, diarrhoea, constipation), and headache. Less frequent side effects include dry mouth, peripheral oedema, dizziness, sleep disturbances, fatigue, paraesthesia, arthralgia, myalgia, rash, and pruritus. Other side effects reported rarely or very rarely include taste disturbance, stomatitis, hepatitis, jaundice, hypersensitivity reactions (including anaphylaxis, bronchospasm), fever, depression, hallucinations, confusion, gynaecomastia, interstitial nephritis, hyponatraemia, hypomagnesaemia (with long-term treatment), blood disorders (including leucopenia, leucocytosis, pancytopenia, thrombocytopenia), visual disturbances, sweating, photosensitivity, alopecia, Stevens-Johnson syndrome, and toxic epidermal necrolysis. By decreasing gastric acidity, proton pump inhibitors may increase the risk of gastro-intestinal infections (including Clostridium difficile infection).There is no side effects seen in patient | Pharmacodynamics | Pantoprazole is a substituted benzimidazole indicated for the short-term treatment (up to 16 weeks) in the healing and symptomatic relief of erosive esophagitis. Pantoprazole is a proton pump inhibitor (PPI) that suppresses the final step in gastric acid production. | Mechanism of action | Pantoprazole is a PPI that suppresses the final step in gastric acid production by forming a covalent bond to two sites of the (H+,K+ )- ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect is dose- related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. | Nursing implication | Monitor for Side effects |

Name | Domperidone | Brand names | Motilium, Nauzelim | Caution | children | Indication | To treat nausea and vomitingNausea related to administration of cafotaxim. | Contraindication | prolactinoma; if increased gastro-intestinal motility harmful | Dosage | 100g, PO, TDS (3 times a day) | Side effects | rarely gastro-intestinal disturbances (including cramps) and hyperprolactinaemia; very rarely ventricular arrhythmias, agitation, drowsiness, nervousness, seizures, extrapyramidal effects, headache, and rashes; also reported QT-interval prolongationThere are no side effects seen in patient. | Pharmacodynamics | Domperidone is a specific blocker of dopamine receptors. It speeds gastro-intestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. | Mechanism of action | Domperidone acts as a gastro-intestinal emptying (delayed) adjunct and peristaltic stimulant. The gastroprokinetic properties of domperidone are related to its peripheral dopamine receptor blocking properties. Domperidone facilitates gastric emptying and decreases small bowel transit time by increasing esophageal and gastric peristalsis and by lowering esophageal sphincter pressure. Antiemetic: The antiemetic properties of domperidone are related to its dopamine receptor blocking activity at both the chemoreceptor trigger zone and at the gastric level. It has strong affinities for the D2 and D3 dopamine receptors, which are found in the chemoreceptor trigger zone, located just outside the blood brain barrier, which - among others - regulates nausea and vomiting | Nursing implication | Monitor for side effects | Name | Bromhexine Hydrochloride | Brand names | Bisolvon | Caution | Gastric ulceration | Indication | As a mucolytic in the management of viscid mucoid secretions associated with bronchitis, bronchiectasis, and sinusitis.To dilute bronchioles to improve gases exchange rate. | Contraindication | BISOLVON CHESTY should not be used in patients known to be hypersensitive to bromhexine or any other component of the formulation.In case of rare hereditary conditions that may be incompatible with an excipient of the product (refer to Precautions), the use of the product is contraindicated. | Dosage | , 10ml, PO, TDS (3 times a day) | Side effects | Immune system disorder, skin and subcutaneous tissue disorders and Respiratory, mediastinal and thoracic disorders Anaphylactic reaction including anaphylactic shock, angioedema, bronchospasm, rash, urticaria, pruritus and other hypersensitivity. | Pharmacodynamics | Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. Preclinically, it has been shown to increase the proportion of serous bronchial secretion. Bromhexine enhances mucus transport by reducing mucus viscosity and by activating the ciliated epithelium (mucociliary clearance). In clinical studies, bromhexine showed a secretolytic and secretomotor effect in the bronchial tract area, which facilitates expectoration and eases cough.Following the administration of bromhexine antibiotic concentrations (amoxycillin, erythromycin, and oxytetracycline) in the sputum and bronchopulmonary secretions are increased. | Nursing implication | Monitor for side effects |

SURGICAL MANAGEMENT * Bullectomy: removal of a portion of the diseased parenchyma. * Pneumonectomy: removal of entire lung * Lobectomy: removal of a lobe * Segmental resection: removal of a segment of a lobe * Lung transplantation PULMONARY REHABILITATION Pulmonary rehabilitation for patient with COPD is well established and widely accepted as a means of alleviates symptoms and optimizes functional status. Pulmonary rehabilitation services are multidisciplinary. It include: * Assessment * Education * Physical reconditioning * Skill training * Psychological support * Teaching * methods to alleviate symptoms * Breathing exercises * Exercise to improve functional status COMPLICATION Some of the complications include; * (Smeltzer,,2008,p.694)
Respiratory insufficiency or failure * Atelectasis * Pulmonary infections * Pneumonia * Pneumothorax * Pulmonary hypertension

1. Vital Signs

Temperature: 360C
Pulse: 84/min
Respiration: 40/min
Blood Pressure: 138/74mmHg
Weight: 40kg
Height: 145cm

2. Respiration

Breathing: irregular
Presence of: Cough, Wheeze, Dyspnea
Smoking: No

3. Circulation

Presence of:warm

4. Neurosensory

Level of consciousness: respond verbally, moves to command and responds to pain.
Orientation: knows time, place and person.
Mood: Anxious
Pupil: equal 5.

6. Skin /Hygiene

Temperature: warm

Turgor: Non Elastic
Integrity: Cannula present

Hair: Clean
Mouth: Moist

Tongue: Moist
Teeth: -
Nails: Clean

7. Food/ fluid /electrolytes

8. Elimination
Urinary:Normal, on nappy related to generalized weakness.
Usual bowel habit:once a day
Last bowel movement:Todaymorning around 8 am

9. Sleep: Usual

10. Sexuality and reproductively: Expressed no concern related to illness.

11. Mental State behavior: Anxious Looking

12. Safety

History of fall:NO
Fall risk level assessment Done: Yes

Perception/ coordination


Auditory: good

13. Mobility
Activity of daily living:needsassistance related to generalized weakness.

In this we will include the care Hawwa is already receiving and the care we can improve. The care Hawwa now receives is shown underlined and bold, as we add new care we can give to Hawwa. Nursing diagnosis | Goal | intervention | rational | 1. Ineffective airway clearance related to bronchoconstriction and increase sputum production | Achieving airway clearance | * Assess the patient * Check vitals every 4th hourly * Administer medication as prescribed. * Encourage eliminate or reduce all pulmonary irritants * Increase fluid intake * Provide steam inhalation. | * To see for Dyspnea and hypoxemia * To have base line data * To relief bronchospasm * To reduce the risk of bronchospasm * To make secretion tin and relief * To loosen the secretion and bronchospasm | 2. Ineffective breathing pattern related to shortness of breath | To maintain and improve breathing pattern | * Inspiratory muscle training and breathing * Encourage and teach diaphragmatic breathing. * Position the patient in fowlers. | * To improve breathing pattern * To increase alveolar ventilation * To increase amount of air expel during expiration. * To open the airway and maintain breathing pattern |

Nursing diagnosis | Goal | intervention | rational | 3. Bathing/ hygiene self-care deficit related to fatigue | Adhere to therapeutic program and more care. | * Give bed bath * Encourage patient to begin to bath self, dress self, walk and drink fluids, discuss energy conservation measures. * Help the patient to take toilet bath with the help of relatives. | * To provide comfort * Encourage the patient to avoid increasing dependence. * Promote the relationship between patient and relatives. | 4. Anxiety related to threat to self concept | Attainment of an optimal level of coping | * Help the patient develop realistic goals * Encourage activity to level of symptom | * Developing realistic goals with promote a sense of hope and accomplishment rather than hopelessness. * Activity reduces tension and decreases degree of Dyspnea as patient becomes conditioned. | 5. Deficient knowledge related to self management to be performed | Adhere to therapeutic program and home care | * Teach the patient about disease, medications procedures and how and when to seek help. * Refer patient to pulmonary rehabilitation | * Patient needs to be partner in developing the plan of care and needs to know what to expect. * Improve quality of life. |
Patient is still not plan to discharge and she had not been told about any discharge plans.
Our discharge plan will include guidance to take medicine, how to recognize side effects, diet plan. * Medicine
Cefotaxime 1g, IV, TDS (3 times a day)
Pantoprazole, 40mg, IV, BD (2 times a day)
Domperidone, 100g, PO, TDS (3 times a day)
Bromhexine hydrochloride, 10ml, PO, TDS (3 times a day)
KCL ampoule 20mg, PO, BD (2 times a day) * If there is any sign of fever, headaches and other side effects such as loose stool and vomiting, immediately consult a health care provider. * Diet plan
Provide small frequent meals because she has decreased appetite and in between meals she can be provided with nuts and fruits as snacks. Time | Types of food | Nutrient | Breakfast | Roshi and fish curry, can change the curry according to the taste.1 glass of ,milk | Carbohydrate,protein, fats | Lunch | 1 cup Rice ,garudiya1 glass Mango juiceCarrot and cucumber | Minerals, carbohydrates, vitamins protein | dinner | 1 cup rice, curry1 glass milkVegetables and fruits. | Vitamins, carbohydrates, protein, minerals | * The nature of Bronchitis as a disease of the airway, which is defined as presence of cough and sputum production for at least 3 months in each 2 consecutive years. * Triggers to avoid * Dust * Passive smoking

During this activity we learned a lot about COPD. Our confidential level to with communicate with patient increased.COPD is very common in Maldives especially in older people.We learned how to manage cases of COPD, read and comparediagnostic test results, plan and imply the most appropriate care according to the patient need, administer medication, its side effects and indication.
. We learned that nursing care given to the patient should be carefully monitored and planed according to the patient’s needs. We compared the care given to the patient with the care that can be improved for the patient. As a nurse we have to plan a comprehensive care to the patient. After doing this care study we have learned how to plan a complete nursing care to the patient who is diagnosed with COPD.

Smeltzer,S.C.,Bare,B.G.,Hinkle,J.L.,&Cheever,K.H.(2010).Brunner and suddarth’s textbook of medical-surgical nursing(12th ed.).Philadelphia:Lippincott Williams & Wilkins.
Wilson, B.A., Shannon, M.T., Shields, K.M. (2011).Pearson Nurse’s Drug Guide 2011.Pearson,USA.
Waugh,A.Grant,A.(2006).Ross and Wilson Anatomy and Physiology in health and illness.(10th ed.).Churchill Livingstone Elsevier,Spain.
Doenges,M.E.,Moorhouse,M.F.,&Geissler-murr,A.C.(2002).Nursing Care Plans Guidelines for individualizing patient care.(6th ed.).Philadelphia:F.A.Davis Company.
Morton,I.,&Hall,J.(1988.).Medicines the comprehensive guide.(1st ed.).Bloomsbury publishing limited, Great Britian.
Pagana,K.D.,&Pagana,T.J.(1998).Mosby’s Manual Of diagnostic and laboratory tests.Mosby.
Rozenberg.G.,(1997).Microscopic haematology a practical guide for the laboratory.Syndey:Harwood academic publisher,Australia.

Similar Documents

Premium Essay

Chronic Obstructive Pulmonary Disease

...Chronic Obstructive Pulmonary Disease is commonly called COPD. COPD is a widely growing cause of disability and mortality in the world every day. COPD was the 6th leading cause for 4% of deaths in the world in 1990 and by 2020 it is projected to increase to 7% and move up to the 3rd cause for deaths in our world. (Lundback, 2003) Causes of COPD can include exposure to indoor and outdoor pollutions, occupational hazards, infections and also with the leading cause of cigarette smoking. With the correct treatment it can be lived with. COPD is a preventable and treatable disease with some effects that may aid to severity in some patients and is not reversible. This is a lung disease that leads to harder breathing. There are two forms of COPD including Chronic Obstructive Bronchitis and Emphysema. Its pulmonary component is characterized by the limit of airflow that is not reversible. The airflow limitation is usually progressive and is associated with an abnormal inflammatory response of the lungs to gases. Airflow is limited because of a mixture of small airway disease, parenchymal destruction or emphysema, and in many cases because of increase in the airway response or asthma. After witnessing a grandmother with COPD having trouble breathing on her own after 2 weeks out of heart surgery and still on the ventilator only through an incision in her neck now, I see the severity of COPD first hand. The risk of getting COPD varies in many ways including genetics, tobacco smokers...

Words: 671 - Pages: 3

Free Essay

Chronic Obstructive Pulmonary Disease (Copd)

...Chronic Obstructive Pulmonary Disease (COPD) Bertha Mitchell September 16, 2014 HCT 101 Professor Joe Gravely COPD an acronym that we hear a lot. But what is it? What causes it? Is there a cure? By medical definition COPD stands for Chronic obstructive pulmonary disease which refers to a group of lung diseases that block airflow and make breathing difficult. (Walsh) Chronic Obstructive Pulmonary Disease is known to cause chronic bronchitis and emphysema. Both are It is commonly caused from smoking cigarettes. Both can severely damage It can cause a person life threatening problems; heart failure, wheezing, coughing, are just a few. COPD can destroy the airway by becoming inflamed and swollen. In addition a person can experience episodes of coughing up mucus, which will cause the alveoli to weaken and loose elasticity. . There are three types of inflammation that are common with COPD: panacinar, ceniacinar, and distal acinar emphysema. Out of the three panacinar emphysema is the most severe, rendering most people unable to work. They experience severe coughing throughout the day and are more susceptible to contract infections. Ceniacinar is not as severe. Most people are able to work, but still will experience episodes of uncontrollable coughing. Distal acinar emphysema is quite rare. COPD is a progressive disease which will worsen over time. COPD is a major cause of disability, and it's the third leading cause of death in the United States. Currently,......

Words: 526 - Pages: 3

Free Essay

Chronic Obstructive Pulmonary Disease Case Study is on a patient by the name of LaToya. LaToya is a fifty-one year-old black female. She was admitted to the medical-surgical department where I work, with a diagnosis of exacerbation of chronic obstructive pulmonary disease. She has a 66 pack-year history, meaning she smoked the equivalent of 365 packs of cigarettes for 66 years, and occasional drug and alcohol use. LaToya is divorced and lives alone in an older apartment building. Chronic obstructive pulmonary disease (COPD) is a lung disease that limits your airflow. COPD may include chronic bronchitis, emphysema, or both. Chronic bronchitis is the production of increased mucus caused by inflammation. Bronchitis is considered chronic if you cough and produce excess mucus most days for three months in a year, two years in a row. Emphysema is a disease that damages the air sacs and/or the smallest breathing tubes in the lungs. COPD is a progressive disease that makes it hard to breathe and the symptoms will get worse over time. Most cases of COPD occur as a result of long-term exposure to lung irritants that damage the lungs and the airways. Cigarette smoking is the leading cause of COPD. Most people who have COPD smoke or used to smoke. One of the greatest challenges for LaToya is to stop smoking. According to the Center for Disease Control (2012), the most important step a smoker can take after getting a COPD diagnosis is to quit. Not only will it make breathing easier, but it will cut down on the risk of severe......

Words: 3632 - Pages: 15

Premium Essay

Chronic Obstructive Pulmonary Disease (Copd; Emphysema) Patho

...Chronic Obstructive Pulmonary Disease (COPD; Emphysema) Pathophysiology Abakyereba Kwansemah June 4, 2014 Abstract a 65-year-old man admitted to medical ward with an exacerbation of chronic obstructive pulmonary disease (COPD; emphysema). Past medical history (PMH) indicates hypertension (HTN), well managed with enalapril (Vasotec) past six years, diagnosis (Dx) of pneumonia yearly for the past three years. D.Z. appears cachectic with difficulty breathing at rest. Patient reports productive cough with thick yellow-green sputum. He seems anxious and irritable during subjective data collection. He states, he has been a 2-pack-a-day smoker for 38 years. He complains of (c/o) insomnia and tiredness. His vital signs (VS) are 162/84, 124, 36, 102° F, SaO2 88%. Admitting diagnosis is chronic emphysema with acute exacerbation. Admitting orders includes: diet as tolerated; out of bed with assistance; oxygen (O2) to maintain SaO2 of 90%; maintenance IV of D5W at 50 ml/hr.; intake and output (I&O); arterial blood gases (ABGs) in AM; CBC with differential, basic metabolic panel (BMP), and theophylline (Theo-Dur) level on admission; chest x-ray (CXR) q24h; prednisone 60 mg/day PO; doxycycline 100 mg PO q12h x10 days, azithromycin 500 mg IV piggyback (IVPB) q24h x2 days then 500 mg PO x 7 days; theophylline 300 mg PO bid; heparin 5000 units SC q12h; albuterol 2.5 mg (0.5 ml) in 3 ml normal saline (NS) and ipratropium 500 mg by nebulizer q4-6h;...

Words: 6939 - Pages: 28

Free Essay

Inhibitory Effect of Viticis Fructus on Lung Inflammatory Responses in an Animal Model of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease

...Chronic obstructive pulmonary disease (COPD) is a complex disease in which airflow obstruction is not fully reversible [1]. It is mainly characterized by airflow limitation and is defined by its character of dyspnea, cough, and sputum production, symptoms that aggravate disease severity and disease exacerbation [29]. It includes emphysema, which is characterized by airspace enlargement and destruction of lung parenchyma, and chronic bronchitis [2]. It is a chronic, progressive inflammatory condition of the small airways and lung parenchyma resulted from elevated pulmonary macrophages, neutrophils, and CD8+ T cells. Proinflammatory mediators, including IL-8, MCP-1, and IL-1β, are elevated in bronchoalveolar lavage fluid (BALF) and sputum samples obtained from patients with COPD [3-6]. Cigarette smoke is a major trigger of airways inflammation [7, 8] due to its concoction of many hundreds of toxic or otherwise bioactive substances, many of which may act in synergy [9]. Cigarette smoke has been identified as the most important risk for the development of COPD [10]. Smoking is the leading risk factor for compromised lung function stemming from COPD pathogenesis [11]. The exposure to cigarette smoke (CS) is associated with emphysema. In addition to chronic lung inflammation, emphysema is known mainly for the complex pathogenesis associated with imbalance of proteolytic and antiproteolytic activites, oxidative stress, and apoptosis of lung structural cells [12]. Roflumilast is......

Words: 516 - Pages: 3

Premium Essay

Hca 240 Final Project

...Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease also referred to as COPD is the name that identifies a group of lung diseases. These diseases consist of bronchiectasis, chronic bronchitis, emphysema, and refractory asthma. An individual can have COPD for years and not know it. When the disease is in the early stages the symptoms are not completely mature and are barely discernible. As the disease matures and progresses the symptoms become more noticeable. Although millions of individuals are living with COPD, this disease is the fourth leading cause of death in the United States; and smoking, second-hand smoke, air pollutants, occupational dust, chemicals, and genetics are factors that can cause the disease for which there is no cure; however numerous treatments are available to help live an active and healthy life (COPD Foundation, 2010). Many people who have COPD are undiagnosed with the disease. Undiagnosis could derive from several reasons, which may include no health insurance, afraid to seek medical attention, or belief that the symptoms are of another illness such as a cold that will not go away. However, most cases of COPD are undiagnosed because of a lack of education concerning the disease. Many communities and employers fail to educate the public concerning diseases like COPD.I was surprised to find that the......

Words: 2779 - Pages: 12

Premium Essay


...COPD COPD is a term used for Chronic obstructive pulmonary disease. This is an “obstructive disease”, meaning that airflow coming out of the lungs during exhalation is blocked. The blockage of airflow with COPD ,makes it very difficult for a person to breathe. Over time, COPD get progressively worse because doctors have not yet found a cure. COPD affects more Than 5% of the adult population, and is a major cause of morbidity and mortality in the United States and worldwide. 4 With COPD, a person will usually have two main medical conditions that limit airflow. These conditions are known as emphysema and chronic obstructive bronchitis. Emphysema causes the elasticity of the lung tissue to be lost. The alveolar walls between air sacs in the lung are damaged, and this causes them to lose their shape and become flimsy. Over time, this damage destroys the walls, leading to fewer, larger air sacs, rather than many, smaller air sacs like that of a normal lung. When this happens, the amount of surface available for gas exchange inside the lung is drastically reduced. With chronic bronchitis, the lining of the airways is constantly irritated and inflamed. This condition causes the lining to thicken, and leads to a lot of thick mucus production forming in the airways, making it harder to breathe. With destruction of the lung parenchymal, and narrowing of the small airways, air becomes trapped due to the inability of the airways to remain open during......

Words: 918 - Pages: 4

Premium Essay


...Chronic obstructive pulmonary disease (COPD) is an umbrella term for people with chronic bronchitis, emphysema, or both. With COPD the airflow to the lungs is restricted (obstructed). COPD is usually caused by smoking. Symptoms include cough and breathlessness. The most important treatment is to stop smoking. Inhalers are commonly used to ease symptoms. Other treatments such as steroids, antibiotics, oxygen, and mucus-thinning (mucolytic) medicines are sometimes prescribed in more severe cases, or during a flare-up (exacerbation) of symptoms Chronic obstructive pulmonary disease (COPD) is a general term which includes the conditions chronic bronchitis and emphysema. COPD is the preferred term. • Chronic means persistent. • Bronchitis is inflammation of the bronchi (the airways of the lungs). • Emphysema is damage to the smaller airways and air sacs (alveoli) of the lungs. • Pulmonary means 'affecting the lungs'. Chronic bronchitis or emphysema can cause obstruction (narrowing) of the airways. Chronic bronchitis and emphysema commonly occur together. The term COPD is used to describe airflow obstruction due to chronic bronchitis. Furthermore COPD is an ongoing and a terminal disease that can have effect on patient daily living (Blackler et al. 2007). In this project, the topic chosen is Developing Self management plans to help people with COPD to control their condition. The key intervention innovating on is the development of COPD care checklist. This is due to......

Words: 521 - Pages: 3

Free Essay

Natural Functioning of Organ Systems second hand smoke. (CDC 2012). Along with all these deaths, the estimated cost to the United States $96 billion in medical bills and $97 billion in lost productivity per year. According to the National Heart, Lung, and Blood Institute people that smoke are six times more likely to suffer from heart attacks. Smoking can also cause cases of chronic obstructive lung disease which includes emphysema and bronchitis. Smoking also put people at a greater risk for having a stroke. Cigarettes that offer low-tar and low-nicotine are not a safe alternative to smoking and have the same effects as normal cigarettes. According to the World Health Organization, reconstituted tobacco is the main ingredient of modern cigarettes. This is referred to as sheet and is made up of recycled stems, dust, stalks, scraps, and floor sweepings. These materials are ground up and nicotine is extracted and chemicals, glue and other fillers are added. Cigarette smoking causes Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Chronic Bronchitis, and Pneumonia. Chronic obstructive pulmonary disease gets worse as time goes by and causes wheezing, shortness of breath, tightness in the chest along with other symptoms. Emphysema is a condition in which...

Words: 513 - Pages: 3

Premium Essay

Chronic Bronchitis

...Chronic Bronchitis HCS/245 02/01/15 Cheryl Meaux Chronic Bronchitis Chronic bronchitis is an inflammation, or irritation, of the airways in the lungs. Airways are the tubes in your lungs that air passes through. They are also called bronchial tubes. When the airways are irritated, thick mucus forms in them. The mucus plugs up the airways and makes it hard for you to get air into your lungs. Symptoms of chronic bronchitis include a cough that produces mucus or sputum, trouble breathing and the feeling of tightness in your chest (, 2014). This form of bronchitis is considered chronic because it can last for a long time. Cigarette smoking is most likely the reason for you getting chronic bronchitis also if you have been exposed for a long time to other things that irritate their lungs, such as chemical fumes, dust and other substances, can also develop chronic bronchitis (, 2014). If chronic bronchitis does not get the treatment needed it can turn into emphysema and the two diseases form together to be called Chronic Obstructive Pulmonary Disease or COPD. It is common that the signs of Chronic Bronchitis can be ignored and most likely recognized when it worsens. The longer you wait to get treatment, the worse your lungs are get. After doing research, I found that Chronic Bronchitis alone is neither primary, secondary, nor tertiary but is actually described in each form. Primary prevention is accomplished by elimination of exposures......

Words: 860 - Pages: 4

Premium Essay


...Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) is an irreversible debilitating disease of the airway that is currently the fourth leading cause of death in the United States and is rising. Chronic obstructive pulmonary disease is treatable but currently there is no known cure and it is a major cause of morbidity and mortality. COPD causes reduction in airflow during the ventilation cycle due to the loss of air way elasticity, narrowing of the airways, chronic airways inflammation and over active mucous production (Frace, 2008). Known risk factors for development of COPD include tobacco use (including second hand smoke), air pollution, dust and exposure to chemicals used in the production of coal, cotton and grain. There are many complications of COPD, the most common are pneumonia, pneumothorax, cor pulmonale, atelectasis, and in severe cases there maybe respiratory insufficiency and failure (Bare, Cheever, Hinkle, & Smeltzer, 2010). Nursing management for a patient with chronic obstructive pulmonary disease begins with assessment; gathering information from the patient including detailed medical history, present symptoms and evaluate findings of diagnostic tests. Symptoms vary with each patient, but may include chronic cough, clubbing of the fingers, chest tightness, weight loss, cyanosis, difficulty breathing with a higher rate of respirations and difficulty sleeping......

Words: 1349 - Pages: 6

Premium Essay


...COPD: Chronic Obstructive Pulmonary Disease Angelia Alleyne HCS/245 May 4, 2015 Professor Lori Olson COPD: Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease, or COPD, is a long-term disease that causes breathing problems. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD, however, is a heterogeneous collection of diseases with differing causes, pathogenic mechanisms, and physiological effects. Therefore a comprehensive approach to COPD prevention will need to address the complexity of COPD. Advances in the understanding of the natural history of COPD and the development of strategies to assess COPD in its early stages make prevention a reasonable, if ambitious, goal. Prevention can be classified as primary, secondary, or tertiary (Rennard, Drummond, 2015). The term COPD is used to describe certain diseases that partially block airflow in the lungs. The most common kinds of COPD include: Emphysema and Chronic bronchitis and other diseases. Emphysema can cause damage to the alveoli that cannot be cured; this is the tiny air sacs of the lungs where oxygen is put into your blood. With emphysema your lungs become less able to take in good air and get rid of carbon dioxide. Chronic bronchitis occurs when the airways in the lungs become swollen; this causes more mucus than normal to be made in the lungs. The swelling and increased mucus can cause the airflow to become partially blocked. ......

Words: 1146 - Pages: 5

Premium Essay

Health Care

...about not having the right supply of air to help me to breath. How many times we have been told to take care of our body and lungs, and fell to do so. I have learn, not maintaining  a healthy way of living dealing with your lungs will led to major problems in the long haul. The disease I will discuss is Chronic Obstructive Pulmonary Disease {COPD}. COPD is the resistance to airflow as a result of airway narrowing. Airway obstruction may result from accumulated secretions, edema, swelling of inner lumen of airway, bronchospasm, or destruction of lung tissue. There three cystic fibrosis that is related to COPD and they are Emphysema, Chronic bronchitis, and Asthma. Chronic Obstructive Pulmonary Disease has a major impact on both physical and psychological well-being {Donna R. Falvo, 420.}  Realizing that this is a life-changing condition, with one cure and treatment [makes you think] ‘what does that mean?’ A pulmonologist told me, “That any person that is face with COPD would have to have a lung transplant to get rede of the disease.” The etiology of Chronic Obstructive Pulmonary Disease {COPD} is that cigarette smoking is the number one reason in developing COPD and is ten times likely to develop this disease. Secondhand smoke exposure can also cause COPD. When this happen hyperplasia in our cells produce more mucous, reduced airway due to hyperplasia, reduce ciliary activity that bring up foreign bodies to cough things up. Cigarette smoke will cause lung damage, which can......

Words: 2989 - Pages: 12

Free Essay

Health Promotion

...Health Promotion According to the World Health Organization (WHO) the definition of health promotion entails a process of enabling people to improve and control their own health. (Health promotion definition, n.d) There are three levels of health promotion which are primary, secondary and tertiary. All three levels are applied to every type of disease. The goal in health promotion is to better educate patients and families in their health so as to alleviate the financial burdens of the public related to disease and the effects of long term conditions that can result from the mismanagement of some conditions. Chronic obstructive pulmonary disease or COPD is one of these conditions that if not managed correctly can lead to financial burden. COPD is a blanket term used for people that are diagnosed with multiple lung dysfunctions such as chronic bronchitis and emphysema. “Chronic obstructive pulmonary disease (COPD) is now the third leading cause of death in Western countries” (Cope, 2014, p. 372). According to the center for disease control (CDC) in 2011 the highest COPD prevalence was in the areas of the Ohio and lower Mississippi rivers. (Data for COPD, n.d).These states include Ohio, Indiana, Kentucky, Tennessee, Mississippi, and Alabama to just name a few. Kentucky and Alabama rank the highest in prevalence most likely due to the farming of tobacco. To help decrease the cost of COPD and the effects of it health promotion has to be provided. So what is the nurse’s role......

Words: 861 - Pages: 4

Premium Essay


...Asthma (from the Greek άσθμα, ásthma, "panting") is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol). Symptoms can be prevented by avoiding triggers, such as allergens[4] and irritants, and by inhaling corticosteroids Leukotriene antagonists are less effective than corticosteroids and thus less preferred. The prevalence of asthma has increased significantly since the 1970s. As of 2009, 300 million people were affected worldwide. In 2009 asthma caused 250,000 deaths globally. Despite this, with proper control of asthma with step down therapy, prognosis is generally good. Reaction: Suggestion: Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive respiratory disease (CORD), refers to chronic bronchitis and emphysema, a pair of commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of air to and from the lungs causing shortness of breath. In clinical practice, COPD is defined by its characteristically low airflow on lung function tests. In contrast to asthma, this limitation......

Words: 2407 - Pages: 10